Cargando…
Efficacy, Safety, and Economics of Innovative Medicines: The Role of Multi-Criteria Decision Analysis and Managed Entry Agreements in Practice and Policy
Through the years, solutions for accelerated access to innovative treatments are implemented in models of regulatory approvals, yet with limited data. Besides efficacy data, providing adequate safety data is key to transferring conditional marketing authorization to final marketing authorization. Ho...
Autores principales: | Fens, Tanja, van Puijenbroek, Eugène P., Postma, Maarten J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757864/ https://www.ncbi.nlm.nih.gov/pubmed/35047908 http://dx.doi.org/10.3389/fmedt.2021.629750 |
Ejemplares similares
-
Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review
por: Fens, Tanja, et al.
Publicado: (2021) -
A Proposal for Value-Based Managed Entry Agreements in an Environment of Technological Change and Economic Challenge for Publicly Funded Healthcare Systems
por: Xoxi, Entela, et al.
Publicado: (2022) -
Reconstructing the Effectiveness of Policy Measures to Avoid Next-Wave COVID-19 Infections and Deaths Using a Dynamic Simulation Model: Implications for Health Technology Assessment
por: Hagens, Arnold, et al.
Publicado: (2022) -
Evaluating carbon-electrode dielectrophoresis under the ASSURED criteria
por: Martinez-Duarte, Rodrigo, et al.
Publicado: (2022) -
Pharmaceutical Innovations: The Grand Challenges Ahead
por: Aroeira, Rita I., et al.
Publicado: (2020)